2024 |
Avantor Inc.
|
Chairman of the Board |
- |
- |
2023 |
Avantor Inc.
|
Chairman of the Board |
430.0 K |
-0.3 % |
2022 |
Avantor Inc.
|
Chairman of the Board |
431.3 K |
31.9 % |
2021 |
Avantor Inc.
|
Lead Independent Director |
326.9 K |
9.0 % |
2021 |
Genmab - ADR
|
Independent Director |
- |
- |
2021 |
Bellerophon Therapeutics Inc
|
Chairman of the Board |
- |
- |
2020 |
Genmab - ADR
|
Independent Director |
1 M |
- |
2020 |
Avantor Inc.
|
Independent Director |
300.0 K |
2.6 % |
2020 |
Bellerophon Therapeutics Inc
|
Chairman of the Board |
10 K |
-95.0 % |
2019 |
Avantor Inc.
|
Independent Director |
292.5 K |
-65.2 % |
2019 |
Bellerophon Therapeutics Inc
|
Chairman of the Board |
200 K |
0.0 % |
2019 |
Genmab - ADR
|
Independent Director |
- |
- |
2018 |
Avantor Inc.
|
Independent Director |
839.8 K |
- |
2018 |
Bellerophon Therapeutics Inc
|
Chairman of the Board |
200 K |
126.2 % |
2017 |
Bellerophon Therapeutics Inc
|
Chairman of the Board |
88.4 K |
- |
2016 |
Bellerophon Therapeutics Inc
|
Chairman of the Board |
- |
- |
2015 |
Bellerophon Therapeutics Inc
|
Chief Executive Officer, President and Chairman of |
- |
- |
2014 |
Bellerophon Therapeutics Inc
|
Chief Executive Officer, President and Chairman of |
- |
- |